Skip to content

Prediction of complications after major gastrointestinal surgery with machine learning and point of care ultrasound: an observational cohort study.

Prediction of complications after major gastrointestinal surgery with machine learning and point of care ultrasound: an observational cohort study. - AI_PLUS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON53240
Enrollment
200
Registered
2023-10-12
Start date
2023-11-29
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perioperatieve complicaties en vochthuishouding/hypotensie perioperative complications and fluid tolerance.

Interventions

None listed

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: >=18 years of age. elective major gastrointestinal surgery: esophagectomy, gastrectomy, pancreactomy or major liver resection (3 segments or more).

Exclusion criteria

Exclusion criteria: - no informed consent - Patients with major cardiac shunts - Patients with dialysis shunts or peritoneal dialysis - Patients in whom POCUS is not possible or assessment of fluid status is unreliable e.g. BMI> 40, pulmonary fibrosis.

Design outcomes

Primary

MeasureTime frame
The main study endpoint is a machine learning framework based on the hemodynamic profile to predict major complications, especially cardiovascular/pulmonary instability, including, sepsis and septic shock. Data from the ClearSight will be used to collect non-invasive arterial pressure waveforms. point of care ultrasound of heart, lungs and abdominal veins, and clinical data from the electronic medical record will be collected

Secondary

MeasureTime frame
point of care ultrasound of heart, lungs and abdominal veins, and clinical data from the electronic medical record will be collected. In a subgroup of 40 patients RAAS levels and portal blood samples will be analysed.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)